We examined the ultrastructural localization of (a) a secondary granule matrix proteineosinophil peroxidase (EPO)by cytochemistry, (b) a secondary granule core protein (major basic protein, MBP) by immunogold labeling, and (c) a primary granule protein (the Charcot-Leyden crystal protein, CLC protein) by immunogold labeling in eosinophilic myelocytes (EMS) and mature, activated eosinophils that differentiated from umbilical cord blood progenitors cultured in the presence of recombinant human interleukin-5 (rhK-5). These studies provide the first substructural localization of MBP to condensing cores of immature secondary granules of EMS, as well as identification of unicompartmental, MBFrich secondary granules that are devoid of matrix compartments and EPO content and are not primary granules mroduction Mature human eosinophils are polymorphonuclear granulocytes with two large granule populations (1). One of these populations consists of primary granules (2,3), which comprise ~5 % of the cytoplasmic large granules, are unicompartmental, increase in activated eosinophils in vivo and in vitro, and are the granule storage organelle for the Charcot-Leyden crystal (CLC) protein (2). The second large granule population consists of secondary (or specific) granules, which comprise ~9 5 % of the large cytoplasmic granules, are bicompartmental, undergo quantitative decreases in number and qualitative morphological changes in activated eosinophils in vivo and in vitro, and are the storage organelle for a number of eosinophil products (reviewed in 1). These include major basic protein (MBP) (4,5), eosinophil-derived neurotoxin (EDN) (4). eosinophil cationic protein (ECP) (4,5), eosinophil peroxidase (EPO) (1,5), and tumor necrosis factor-a ( m a ) (6). MBP is confined to the
by virtue of their la& of CLC protein. These granules occur in quantity in L5-activated mature human eosinophils, which have previously been shown to actively transport EPO from the matrix compartments of their secondary granules to the extracellular milieu in smooth membrane-bound cytoplasmic vesicles, a secretory process termed piecemeal degranulation, whereby eosinophils progressively empty cytoplasmic granules of their contents in the absence of classical central crystalline core of the bicompartmental secondary granules; the remaining granule proteins are present in the matrix compartment beneath the granule membrane and surrounding the central crystalline core. The secondary granule eosinophil proteins share a common functional potential, i.e., cytotoxicity (7,8), and these proteins, if directed towards invading parasites, might be beneficial for the resolution of disease but, when directed to host cells, are an important facet of disease pathogenesis. Understanding the basic secretory mechanisms of these cytotoxic granule proteins from eosinophils is important to the development of targeted, therapeutic inhibition or augmentation of their release from intact cells.
Mature human eosinophils can release their secondary granules in toto by extrusion (9,10), as observed in bacteria-infected biopsies of small bowel (9). Alternatively, secondary granules may release the contents of these granules, retaining empty granule chambers in the cytoplasm, a process we termed piecemeal degranulation (PMD) to account for the prominent presence of these empty granule containers (or vacuoles) (11) in activated cells (12). Eosinophils may also individually empty either matrix or core compartments of secondary granules during PMD (12). Emptying of the matrix compartment constituent EPO is mediated by vesicular transport of this granule protein (13). EPO-loaded vesicles, as visualized by ultrastructural cytochemistry. bud from granules, traverse the cytoplasm, and empty their contents onto the cell surface (13). The differential release of secondary granule proteins and crystalline cores has been demonstrated with post-embedding immunogold labeling of the matrix and core proteins (14), thereby supporting a previous routine ultrastructural analysis (15) .
Core blood-derived progenitors that give rise to eosinophils in the presence of interleukin-5 in culture provide a model system for studies of the differentiation and maturation of this lineage in vitro (12, 13, (16) (17) (18) (19) . The addition of IL5 also yields biochemical and morphological evidence for the activation of mature eosinophils (12, 13, 17, (19) (20) (21) (22) . including the vesicular transport out of cells of the secondary granule matrix protein EPO (13). Mature eosinophils undergoing these changes in vitro often demonstrate qualitative and quantitative morphological changes in their large granule populations.
We used ultrastructural cytochemistry to detect EPO and ultrastructural immunogold labeling to detect CLC protein and MBP in cultures of human cord blood cells supplemented with rhIL5 to localize these eosinophil products during differentiation, maturation, and activation of the eosinophil lineage. The studies reported here show that MBP, CLC protein, and EPO have different subcellular distributions in immature eosinophilic myelocytes duting granulogenesis and in mature granulated eosinophils. In addition, IL5 activation of mature eosinophils gave rise to a population of large, unicomparunental granules that were completely filled with MBP. The combined cytochemical detection of EPO and immunogold localization of MBP showed that these altered granules resulted from emptying of the matrix compartment of secondary granules. Therefore, secondary granules that were filled with MBP were smaller than unaltered secondary granules at the expense of large reductions in the EPO content of their matrix compartments.
Materials and Methods
Suspension Cultures of Umbilical Cord Blood Cells. Suspension cultures of umbilical cord blood were prepared as before (12, 13, 16, 17) . Some cultures were supplemented with rhIL5 alone (23) or with rhIL5 plus a fraction of phytohemagglutinin (€'HA)-stimulated T-lymphocyte culture supernatant from which IL2 had been depleted (24). Cell cultures were harvested at 3-and 5-week intervals and were prepared for ultrastructural studies (25).
Fixation for Electron Microscopy. Cells were fixed in suspension with a tenfold dilution of an aldehyde mixture calculated to yield a final concentration of 1% paraformaldehyde, 1.25 % glutaraldehyde, 0.025% CaCh in 0.1 M sodium cacodylate buffer, pH 7.4, 20%. After fixation for 1 hr at room temperature (RT), cells were washed and re-suspended in cold 0.1 M sodium cacodylate buffer.
Processing for Routine and Post-embedding Immunogold Electron Microscopy. Fued cells in cold 0.1 M sodium cacodylate buffer were infiltrated with melted 2% Difco agar (Difco Laboratories; Detroit, MI) and centrifuged.
The cell-containing agar pellet was then post-fixed for 2 hr in 2% collidinebuffered Os04 at 2O' C, stained en bloc with uranyl acetate (25), dehydrated in a graded series of alcohols, and embedded in a propylene oxide-Epon sequence. Thin sections were either directly stained with dilute lead citrate for 3 min and examined in a Philips 400 or 300 electron micro-"ope (North American Philips; Mahwah, NJ) or examined after immunogold and lead citrate staining.
procesSing for Cytochemical Detection of Peroxidase Activity. Cells fixed as above were washed and incubated in suspension in the following solutions: (a) three washes in 0.05 M %is-HC1 buffer, pH 7.6; (b) 5 mg 3-3'diaminobenzidine tetrahydrochloride (DAB.4HCI) (Polysciences; Warrington, PA), 0.01% H202, 10 mlO.05 M Tris-HC1 buffer, pH 7.6, at multiple times ( 5 , 10, 15, 30, and 60 min); (c) three washes, as in (a) above. Further processing included centrifugation of cells in molten agar to form cell pellets.
The samples were post-fued in 1.5% collidine-buffcred os04 for 2 hr, 4'C. dehydrated in a graded series of alcohols, infiltrated, and embedded in a propylene oxide-Epon sequence. Control samples were processed similarly except for omission of specific substrate (DAB.4HCI) in the incubation media. Thin sections were examined either unstained or after lead citrate staining, as above.
Immunogold Procedure to Detect MBP and CLC Protein. Thin sections of routine and cytochemical preparations of cultured eosinophils were prepared and collected on gold grids for the immunogold procedures. Human eosinophil granule MBP was purified to homogeneity from isolated eosinophil granules as previously described (26, 27) . Briefly, eosinophil granules were solubilized in 0.01 N HCI with sonication, pH adjusted to 2-3, and the granule cationic proteins separated on a 47 x 1.5-cm Sephadex G-50 column equilibrated with 0.025 M Na-acetate buffer. pH 4.2, con- Table 1 in TBS-BSA, 0.1% Tween-20, 0.4% gelatin. 1% normal goat serum, 1 hr; (g) two washes of 10 min each in TBS-BSA; (h) two washes of 10 min each in distilled water.
. Ultrastmctural localization of MBP, CLC protein, and peroxidase in human eosinophils that develop f i m cord blood cells in rhIL-5-supplemented suspension cultures
Controls included the following alterations of the standard sequence described above: (a) omission of primary antibody; (b) substitution of irrelevant rabbit polyclonal antibodies for primary antibodies to MBP or CLC protein; (c) substitution of pre-immune rabbit antiserum for the MBP primary antibody; and (d) substitution of non-immune rabbit IgG at equivalent concentration for the CLC protein affinity chromatography-purified primary antibody.
Results

General Ultrastructural Features of Eosinophilic Myelocytes Arising in rhIL5-containing Cultures of Human Cord Blood Cell..
Eosinophilic myelocytes (EMS) were large mononuclear cells filled with dilated cisterns of rough endoplasmic reticulum (RER) and immature secretory granules ( Figures 1A and 1B) . Golgi structures were usually plentiful. The majority of membrane-bound immature secretory granules were spherical structures that either were homogeneously dense or showed bicompartmental development, characteristic of secondary granules, the most plentiful granule population in mature eosinophils. These immature secondary granules had rounded structures in their central core compartment and an outer electron-lucent or moderately dense matrix compartment ( Figures 1A and 1B) . Eosinophilic myelocytes present in 3-week cultures of cord blood cells (16) contained small numbers of immature primary granules filled with loosely granular and moderately electron-dense material (sometimes surrounded by small vesicles), but homogeneously dense core material was absent. Incubation in cytochemical substrate to demonstrate peroxidase revealed this entyme in the cistern surrounding the nucleus, in RER cisterns, in Golgi structures, and in immature granules, but not in the core compartment of developing secondary granules (16) .
is an irrelevant antibody for anti-CLC protein antibody and vice versa. For example, antisera to MBP did not label CLC proteinpositive structures, and antibody to CLC protein did not label MBP structures.
Distribution of MBP in Eosinophilic Myelocytes In Vitro
MBP was localized to homogeneously dense core material in the core compartment of developing, immature secondary granules of EMS ( Figure 1A ; Table 1 ). The matrix compartment did not contain MBP. All other cytoplasmic organelles (including RER cisterns, perinuclear cisterns, and Golgi structures) did not label for MBP. The nucleus and mitochondria were not labeled. Controls for the immunogold procedure were negative (Figure 1B) . Neutrophilic myelocytes, also present in small numbers, did not contain MBP in their prominent azurophilic granules, thus serving as a good internal control for the specificity of the immunogold procedure to localize MBP ( Figure IC) .
Immunogold stains for MBP showed a distribution in EMS that was different from that for CLC protein ( Table 1) . CLC protein was diffusely present in the nucleus and cytoplasm (12) but absent from secondary granules ( Figure IF ) that filled EMS present in 3-weekold cultures. Substitution of pre-immune rabbit serum for the specific primary rabbit antibody to MBP (or non-immune rabbit IgG for the specific antibody to CLC protein) or omission of the primary antibody in the staining sequence (specificity controls for the immunogold stains) yielded negative results (Figure 1) . In addition, each polyclonal primary rabbit antibody also served as an irrelevant antibody control for the other in this study, i.e.. anti-MBP
General Ultrastructural Features of Mature Eosinophils That Differentiate in rhILS-containing Cultures of Human Cord Blood Progenitors
Mature eosinophils were approximately one third smaller than their immature counterparts (17) . They had polylobed nuclei within which chromatin was heavily condensed. Their cytoplasm contained mature, membrane-bound granules that often showed significant differences from the well-described bicompartmental secondary granules present in vivo in peripheral blood samples (1). In a number of these granules the outer matrix compartment was empty; the central cores were rounded and irregularly shaped (12.17). Other granules were almost homogeneously dense with a marked reduction in the matrix compartment. Cytoplasmic vesicles were numerous. Incubation in cytochemical substrate to detect peroxidase (Figure 2) revealed some secondary granules with a full complement of peroxidase in the matrix compartment (U), as well as peroxidasepositive cytoplasmic vesicles ( Figure 2D ; Table 1 ) (13). The secondary granules with central cores and empty matrix compartments were devoid of peroxidase, a matrix protein ( Figure 2C ). Some granules contained residual, focal peroxidase activity in matrix compartments, which were markedly reduced and partially enveloped peroxidase-negative central cores (Figures 2A and 2B) . Many small, unicompartmental, spherical granules with homogeneously dense, core-like contents were completely devoid of peroxidase (Figure 2D) .
Focal peroxidase-positive patches were attached to the surfaces of mature eosinophils. Controls for the cytochemical method were negative, and the inherent electron density of unstained. osmicated eosinophil granules did not approximate that of positive cytochemical reaction product.
Distribution of MBP in Mature Eosinophils In Vitro
MBP was present in rounded, irregularly shaped cores of bicompartmental secondary granules from which matrix materials appeared absent in an expanded, electron-lucent structure (Table 1) . MBP was also present throughout the homogeneously dense material that filled the unicompartmental, spherically shaped, membrane-bound secondary granules ( Figure 3A) . Many of these granules were reduced in size. Cytoplasmic vesicles did not contain MBP. Immunogold stains to detect MBP were also done on samples previously incubated in cytochemical substrate to detect peroxidase. In this case, MBP-positive granules, which did not contain peroxidase, were detected ( Figure 4A) . The nuclei and cytoplasm of mature eosinophils did not label for MBP, and specificity controls for MBP localization were negative ( Figures 3B and 4B ).
Discussion
A post-embedding immunogold technique was used to identlfy substructural sites of MBP in human eosinophilic myelocytes and mature eosinophils that differentiate and mature in IL5-containing suspension cultures of umbilical cord blood progenitors. Two culture times were selected to study both EMS (3 weeks) (16, 17) and mature cells (5 weeks) (12, 13, 17) . MBP was present in the rounded and irregularly shaped cores of immature secondary granules in EMS in 3-week-old cultures but not in the extensive, dilated cisterns of RER that filled the cytoplasm of these immature eosinophil precursors. MBP was absent from Golgi structures, cytoplasm, and nucleus. Another eosinophil protein, CLC protein, was also labeled by an immunogold method in these immature cells. As reported previously (12) CLC protein was located diffusely in the cytoplasm and nucleus of EMS. Immature secondary granules, Golgi structures, RER, and perinuclear cistems did not label for CLC protein, whereas small numbers of immature primary granules contained CLC protein in their loosely granular matrices (Dvorak et al., unpublished data) .
Several possibilities might account for the lack of MBP in the prominent synthetic structures of EMS. The number of antigenic binding sites may be sufficiently small in this organelle that a postembedding method (which accesses only those antigenic sites on the cut surfaces of very thin sections) cannot visibly label them. Alternatively, MBP may be present in the RER and Golgi as pro-MBP, requiring intragranular processing before detection with antibody prepared against the granule-derived protein can occur (31, 32) . Whatever the reason for the non-detection of MBP in these subcellular compartments, MBP was routinely present in immature secondary granule cores of EMs in the same cells, representing the first ultrastructural localization of MBP in these maturing granules.
The ultrastructural localization of MBP in EMS that we have achieved in cultured cells substantially agrees with that described by light microscopic immunofluorescence of similarly derived cells (16) . For example, MBP was localized to granules, whereas CLC protein was localized to nucleus and cytoplasm (16) ; the latter localization was also observed by electron microscopy (12). In addition, the description of a lacy CLC protein distribution in the cytoplasm by LM (16) coincides with the finding reported here: the immature secondary granules prevailing in EMS do not label for CLC protein. Therefore, the distribution of these two eosinophil proteins in EMS is different, as assessed by both light and electron microscopy. Previously, we found the distribution of CLC protein in activated, cultured mature eosinophils to be diffuse in the nucleus and cytoplasm and to spare secondary granules (12). Small numbers of CLC protein-positive, immature primary granules were present in EMS (Dvorak et al., unpublished data) , and residual mature primary granules in mature eosinophils (~5 % of all granules) contained CLC protein (2,12). Whether or not less mature eosinophil precursors contain greater numbers of immature primary granules is not yet known.
Eosinophilic myelocytes arising in similar cultures have been shown to contain peroxidase in synthetic organelles by a cytochemical technique (16) . Secretory organelles and immature granules devoid of cores were all intensely positive. The matrix portion of immature secondary granules was positive, but their central cores were not (16) . In certain circumstances, vesicular transport of peroxidase was identified in cells from which the matrix peroxidase had been released (33). These cells undergoing PMD retained their immature secondary granule cores but had diminished to absent EPO-positive synthetic organelles and granular EPO content (33). These large EMS did not continue to develop into mature cells until permissive media, known to contain IL3, were added (34).
The immunogold method also detected MBP in secondary granules of mature eosinophils that developed in IL5-containing suspension cultures of cord blood cells. The distribution of MBP differed somewhat from that reported previously for peripheral blood eosinophils (4,s). MBP in peripheral blood eosinophils was precisely localized to the central cores of secondary granules by two groups (4,5), confiiing biochemical studies in which isolated cores were shown to contain MBP (35). The mature eosinophils that we studied in vitro were activated cells in which we detected piecemeal degranulation by routine ultrastructural methods (U), i.e., we showed that matrix compartments of secondary granules were being emptied of peroxidase content by transportation in small vesicles which were released at the cell's surface, but that most core compartments were not being emptied from mature eosinophils in these IL5-containing cultures (13). Moreover, we observed cells with large numbers of smaller, homogeneously dense granules, the precise nature of which was uncertain. The results of the present work suggest that progressive losses of matrix peroxidase result in the development of unicompartmental secondary granules filled with MBP, a granule protein believed to reside only in the core compartment of secondary granules. An altemative explanation for the presence of unicompartmental secondary granules filled with MBP, i.e., de n m production, is less likely on the basis of presently available ultrastructural, morphological, cytochemical, and immunocytochemical evidence.
In aggregate, these studies show that MBP is produced in quantity in the eosinophil lineage developing in vitro from cord blood progenitors and that this protein is located in the condensing cores of immature secondary granules. Furthermore, we show that when a secondary granule matrix protein @PO) is actively r&ased bY vesicular transport (13,33), the mauix compartment is reduced, such that MBP-rich core material fills the secondary granules completely, resulting in smaller, unicompartmental secondary granules in mature eosinophils. In a recent study (19) of mature peripheral blood eosinophils maintained in rhIL5-supplemented cultures for up to 14 days, it was noted that 60% of a matrix protein, EDN, was present in the culture supernatant by Day 7. Other granule matrix proteins (ECP, EPO) were also released in these cultures. This secretory pattern was associated with the development of secondary granule electron lucency (19) . In only one of three experiments, MBP was also detected in the supematant fluid; this was thought to reflect the difficulty of assaying for this sticky protein (19) . It is also possible that MBP was retained in secondary granules from which the matrix proteins were differentially released, as we have shown here. The differential release of EPO, but not ECP (another matrix constituent), has also been reported for activated, hypodense eosinophils (36). Hereditary disorders have been described that result in unusual eosinophil phenotypes. For example, patients with EPO-deficient eosinophils (37-39) have been reported. Eosinophils in these patients show either complete or partial decreases in EPO, assayed biochemically or by uluastructural cytochemistry (37, 38) . The partial and complete losses of the secondary granule matrix protein EPO in these patients could reflect peroxidase transport from cells. The retention of unicompartmental, MBP-rich secondary granules devoid of EPO in eosinophils that develop from cord blood progenitors cultured in rhIL5, as described here, gives rise to secondary granules that are morphologically similar to the EPO-deficient granules of patients with EPO deficiency (37-39). 
